Adkin Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 24 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 32.37%
- Ebitda 100.00%
- Net Worth -3.19%
- Total Assets -0.87%
About Adkin Bioceuticals
Adkin Bioceuticals Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 08 January 2020 (Five years 24 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Pahal, Deepak Bambha, Raja Ram, and Two other members serve as directors at the Company.
Company Details
-
Location
Gurugram, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230HR2020PTC084638
-
Company No.
084638
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
08 Jan 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Adkin Bioceuticals?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Pahal
|
Director | 08-Sep-2023 | Current |
|
Deepak Bambha
|
Director | 08-Sep-2023 | Current |
|
Raja Ram
|
Director | 11-Sep-2023 | Current |
|
Rajesh Kumar
|
Director | 01-Feb-2022 | Current |
|
Naresh Kumar
|
Additional Director | 12-Feb-2022 | Current |
Financial Performance of Adkin Bioceuticals.
Adkin Bioceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 32.37% increase in profit. The company's net worth dipped by a decrease of 3.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Adkin Bioceuticals?
Unlock access to Adkin Bioceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Omen Electrical & Gas Appliances Private LimitedSanjay Pahal is a mutual person
-
Zee Laboratories LimitedDeepak Bambha is a mutual person
-
Oditi Appliances LlpSanjay Pahal is a mutual person
-
Oditi Appliances Private Limited
Sanjay Pahal is a mutual person
-
Oditi Home Appliances Private Limited
Sanjay Pahal is a mutual person
-
Medibruk Pharma Private Limited
Deepak Bambha is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Adkin Bioceuticals?
Unlock and access historical data on people associated with Adkin Bioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Adkin Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Adkin Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.